an experimental cancer drug axed over poor results may have the ability to reverse the effects of alzheimer 's , experts have revealed.
the drug was developed by the uk pharmaceutical giant astra zeneca with the original aim of treating certain types of tumour , but was shelved after it proved ineffective.
scientists at yale university in connecticut in the us have revealed how the treatment , called azdo5030 , restored memory in mice given alzheimer 's disease.
an experimental cancer drug axed over poor results may have the ability to reverse the effects of alzheimer 's , experts have revealed ( file picture ) the drug worked by blocking a process that breaks nerve connections in the brain used to store memory